Growth Metrics

OmniAb (OABI) Debt to Equity (2021 - 2026)

OmniAb (OABI) reported Debt to Equity of $0.0 for Q1 2026, up 195.6% year-over-year from $0.0 in Q1 2025, and down 2.42% on a QoQ basis from $0.0 in Q4 2025.

OmniAb (OABI) has 6 years of Debt to Equity data on file, last reported at $0.0 in Q1 2026.

  • Quarterly Debt to Equity rose 195.6% year-over-year to $0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $0.0 (up 195.6% YoY) and the FY2025 annual result came in at $0.0, up 111.77% from the prior year.
  • Debt to Equity slipped to $0.0 in Q1 2026 per OABI's latest filing, from $0.0 in the prior quarter.
  • Across five years, Debt to Equity topped out at $0.01 in Q4 2022 and bottomed at $0.0 in Q1 2022.
  • The 5-year median for Debt to Equity is $0.0 (2024), against an average of $0.0.
  • The widest annual swing landed in 2023, when Debt to Equity jumped 3725.38%; it then slumped 86.76% in 2024.
  • Tracing OABI's Debt to Equity over 5 years: stood at $0.01 in 2022, then plunged by 64.84% to $0.0 in 2023, then sank by 55.43% to $0.0 in 2024, then jumped by 111.77% to $0.0 in 2025, then slipped by 2.42% to $0.0 in 2026.
  • Per Business Quant, the three latest OABI Debt to Equity figures stand at $0.0 (Q1 2026), $0.0 (Q4 2025), and $0.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.06
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 OmniAb 334.72 Mn 291.75 Mn 14.41 Mn 0.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.00
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.01
Jun 30, 2023 0.01
Mar 31, 2023 0.01
Dec 31, 2022 0.01
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 0.00
Dec 31, 2021 0.01
Jun 30, 2021 0.00